Intracerebroventricular neuropeptide Y acutely influences glucose metabolism and insulin sensitivity in the rat

Journal of Neuroendocrinology

Volumn 9, Issue 2, 1997, Pages 99-103

  Marks, Jonathan L ^a   Waite, Kay ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

Hypothalamus; Insulin; Insulin resistance glucose; Metabolism; Neuropeptide Y

Indexed keywords

CORTICOSTERONE; GLUCAGON; GLUCOSE; INSULIN; NEUROPEPTIDE Y;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; BRAIN THIRD VENTRICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; ENERGY EXPENDITURE; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE INFUSION; GLUCOSE METABOLISM; HYPERINSULINEMIA; HYPOTHALAMUS; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY QUOTIENT;

EID: 0031017829     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.1997.00554.x     Document Type: Article

References (27)

1. Tatemoto K, Carlquist M, Mutt V. Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 1982; 296: 659-660.
2. Allen YS, Adrian TE, Allen JM, et al. Neuropeptide Y distribution in the rat brain. Science 1983; 221: 877-879.
3. Beck B, Burlet A, Nicolas J-P, Burlet C. Hyperphagia in obesity is associated with a central peptideraic dysreaulation in rats. J Nutr 1990; 120: 806-811.
4. Williams G, Gill JS, Lee YC, Carduso HM, Okpere BE, Bloom SR. Increased neuropeptide Y concentrations in specific hypothalamic regions of streptozotocin-induced diabetic rats. Diabetes 1989; 38: 321-327.
5. Clark JT, Kalra PS, Crowley WR, Kalra SP. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behaviour in rats. Endocrinology 1984; 115: 427-429.
6. Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF. Neuropeptide Y chronically injected into the hypothalamus, a powerful neurochemical inducer of hyperphagia and obesity. Peptides 1986; 7: 1189-1192.
7. Marks JL, Waite K, Davies L. Intracerebroventricular neuropeptide Y produces hyperinsulinemia in the presence and absence of food. Physiol Behav. 1996; in press.
8. Menedez JA, McGregor IS; Healey PA, Atrens DM, Leibowitz SF. Metabolic effects of neuropeptide Y injected into the paraventricular nucleus of the hypothalamus. Brain Res 1990; 516: 8-14.
9. Billington CJ, Briggs JE, Grace M, Levine AS. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am J Physiol 1991; 260: R321-327.
10. Marks J, Waite K. Some acute effects of intracerebroventricular neuropeptide Y on insulin secretion and glucose metabolism in the rat. J Neuroendocrinol. 1996; in press.
11. Abe M, Saito M, Shimazu T. Neuropeptide Y and norepinephrine injected into the paraventricular nucleus of the hypothalamus activate endocrine pancreas. Biomed Res 1989; 10: 431-436.
12. Wahlstedt C, Skagerberg G, Ekman R, Heilag M, Sundler F, Hakanson R. Neuropeptide Y in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axix in the rat. Brain Res 1987; 17: 33-38.
13. Leibowitz SF, Sladek C, Spencer L et al. Neuropeptide Y, epinephrine and norepinephrine in the paraventricular nucleus: stimulation of feeding and the release of corticosterone, vasopressin and glucose. Brain Res Bull 1988; 21: 905-912.
14. Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 1993; 133: 1753-1758.
15. Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B. Intracerebroventricular administration of neuropeptide Y administration to normal rats has divergent effects on glucose utilization by adipose tissue and skeletal muscle. Diabetes 1994; 43: 764-769.
16. Vettor R, Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B. Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats. Diabetologia 1994; 37: 1202-1208
17. van Dijk G, Bottone AE, Strubbe JH, Steffens AB. Hormonal and metabolic effects of paraventricular hypothalamic administration of neuropeptide Y during rest and feeding. Brain Res 1994; 660: 96-103.
18. Radziuk J, Norwich KH, Vranic M. Experimental validation of measurements of glucose turnover in non-steady state. Am J Physiol 1978; 234: E84-93
19. Morley JE, Levine As, Gosnell BA, Kneip J, Grace M. Effect of Neuropeptide Y on ingestive behaviors in the rat. Am Physiol 1987; 252: R599-609
20. Clark PW, Jenkins AB, Kraegen EW. Pentobarbital reduces basal liver glucose output and its insulin suppression in rats. Am J Physiol 1990; 258: E701-707.
21. Terrettaz J, Jeanrenaud B. In vivo hepatic and peripheral insulin resistance in genetically obese (fa/fa) rats. Endocrinology 1983; 112: 1346-1351.
22. Nishimura H, Kuzuya H, Okamato M et al. Postreceptor defect in insulin action in streptozotocin-induced diabetic rats. Am J Physiol 1989; 256: E624-630.
23. Gore AC, Mitsushima D, Terasawa E. A possible role of neuropeptide Y in the control of the onset of puberty in female rhesus monkeys. Neuroendocrinology 1993; 58: 23-34.
24. Amiel SA, Caprio S, Sherwin RS, Plewe G, Haymond MW, Tamberlane WV. Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab 1991; 72: 277-282.
25. Lang CH, Ajmal M, Baillie AGS. Neural control of glucose uptake by skeletal muscle after central administration of NMDA. Am J Physiol 1995; 268: R492-R497.
26. Jeanrenaud B, Rohner-Jeanrenaud F, Cusin I et al. The importance of the brain in the etiology of obesity and type 2 diabetes. Int J Obesity 1992; 16: (Suppl 2) S9-S12. 35: 31-41.
27. Jeanrenaud B, Rohner-Jeanrenaud F, Cusin I et al. The importance of the brain in the etiology of obesity and type 2 diabetes. Int J Obesity 1992; 16: (Suppl 2) S9-S12. 35: 31-41.